Introduction {#s1}
============

Dopaminergic neurons located in the ventral midbrain (mDA) give rise to the mesostriatal, mesocortical, and mesolimbic pathways. The vast majority (around 80%) of mDA neurons are born at E12 in rats (Gates et al., [@B14]) in the ventral aqueductal ventricular zone. Then they become post-mitotic, enter into a differentiation and specification program, and migrate ventrolaterally and rostrally along radial glia processes to their final location in the tegmental mantle to form the A8--A10 subgroups (Kawano et al., [@B20]; Hall et al., [@B16]). They start extending processes at E13 in rats (Moon and Herkenham, [@B24]; van der Kooy and Fishell, [@B36]; Voorn et al., [@B37]; Fishell and van der Kooy, [@B12]; Gates et al., [@B14]; van den Heuvel and Pasterkamp, [@B35]). Tyrosine hydroxylase (TH), the rate limiting enzyme for catecholamine synthesis, is localized in the growing tips of axons, and TH-positive (TH^+^) axonal processes are first detected within the ventrolateral developing striatum at E14.5 where they form a few specialized contacts with striatal somas or near the origin of dendrites (Specht et al., [@B28],[@B29]). Accordingly, dopamine is first detected in the forebrain at E13 in mice and DA binding sites (D1-like and D2-like) are present in the embryonic rodent neostriatum from E14 (Ohtani et al., [@B25]; Goffin et al., [@B15]). In addition, antidromic activation of rat substantia nigra compacta (SNc, A9) neurons from the striatum at P0 *in vivo* confirms the presence of the nigro-striatal DA pathway at birth (Tepper et al., [@B31]; Trent et al., [@B33]). Collectively, these studies suggest that the nigro-striatal system is ready to operate at late embryonic stages but the functionality of this pathway and whether it does release dopamine has not been established. This information is important as it conditions our understanding of the operation and role of this system during development.

Here, we combined electrophysiological and imaging studies to describe the developmental sequences of neuronal and network activity, with dopamine release experiments to detect the earliest evoked release of DA in the striatum. Since perinatal mDA neurons cannot be always identified by their adult electrophysiological characteristics (Washio et al., [@B38]) or their localization, we performed our experiments in brain slices from TH-GFP mice (Sawamoto et al., [@B26]). Our results show that at birth (P0), a subpopulation (20%) of mDA neurons spontaneously generate full amplitude Na^+^ spikes, in an intrinsically drive tonic or bursting pattern. At the same age, dopaminergic fibers release dopamine in a calcium-dependent manner in the striatum upon stimulation. Therefore, this suggests that mouse striatal dopaminergic synapses are functional at birth.

Methods {#s2}
=======

Animals and slices
------------------

We performed experiments on wild-type or TH-GFP C57BL/6 mice (Matsushita et al., [@B23]) maintained in our institutional animal facility. Female mice were examined for the presence of a vaginal plug the morning after mating. The day of plug discovery was designated as embryonic day 0 (E0). Experiments were performed on mice of either sex. We removed E16 and E18 mice from deeply anesthetized dams \[subcutaneous injection of a mixture of xylazine (Rompun 2%; used at 0.05%) and ketamine (Imalgene 1000 used at 50 g/L) volume injected: 0.1 mL/10 g\]. The embryos were kept in an ice-cold oxygenated solution containing (in mM): 110 choline, 2.5 KCl, 1.25 NaH~2~PO~4~, 7 MgCl~2~, 0.5 CaCl~2~, 25 NaHCO~3~, 7 glucose. Postnatal mice (P0--P7) were killed by decapitation under isofluorane anaesthesia. Coronal and parasagittal slices (400 μ m thick) were cut in the ice-cold oxygenated choline solution using a vibratome (VT1200 Leica Microsystems Germany). During the recovery period, slices were placed at room temperature with standard artificial cerebrospinal fluid (ACSF) saturated with 95%O~2~/5%CO~2~ and containing the following (in mM): 126 NaCl, 3.5 KCl, 1.2 NaH~2~PO~4~, 1.3 MgCl~2~, 2 CaCl~2~, 25 NaHCO~3~, 11 glucose.

Calcium imaging
---------------

Slices were incubated in the dark with 25 μ L of a fura-2 AM solution (1 mM in DMSO + 0.8% pluronic acid; Molecular Probes). We performed imaging studies with a multibeam two-photon laser scanning system (Trimscope-LaVision Biotec) coupled to an Olympus microscope. Slices were imaged using a high numerical aperture objective (20×, NA 0.95, Olympus). Images (4 × 4 binning) were acquired via a CCD camera (La Vision Imager 3QE) with a time resolution of 115--147 ms per frame. Size of the scan field (444 × 336 μ m) and duration of the movies (1000 frames) were unchanged. We first took images of the GFP-expressing neurons located in the mesencephalon (laser at 910 nm) before acquiring spontaneous fura-2 fluorescence changes (laser at 780 nm). To verify the location of the recorded field, at the end of the imaging session we bleached the fura-2 fluorescence from the field and observed its corresponding location on the GFP image. During the analysis, GFP-expressing fura 2-loaded neurons were identified by superposing the two fields. We performed analysis of the calcium activity with custom-made software written in Matlab (MathWorks) (Bonifazi et al., [@B4]). Active cells were neurons exhibiting any Ca^2+^ event of at least 5% DF/F deflection within the period of recording. Ca^2+^ spike or Ca^2+^ plateau cells were neurons exhibiting at least one Ca^2+^ spike or one Ca^2+^ plateau within the period of recording. A calcium plateau sustained a calcium level for at least 30 frames as opposed to a calcium spike which started decaying at the peak. We computed the activity correlation of cell pairs as previously described (Crepel et al., [@B8]; Dehorter et al., [@B10]).

Patch clamp recordings
----------------------

We performed all recordings at 32°C. Cells were visualized with infrared--differential interference optics (Axioskop2; Zeiss). For whole-cell current clamp recordings the pipette (6--10 MΩ) contained the following (in mM): 128.5 K-gluconate, 11.5 KCl, 1 CaCl~2~, 10 HEPES, 10 EGTA, 2.5 MgATP and 0.3 NaGFP, pH 7.2--7.4 (275--285 mOsm). We determined input membrane resistance (*R*~*m*~) by on-line fitting analysis of the transient currents in response to a 5--10 mV pulse at *V*~*H*~ = --60 mV. Criteria for considering a recording included *R*~*m*~ \> 100 MΩ. The input resistance (*R*~*m*~) of mDA neurons decreased significantly from 355 ± 39 MΩ before birth (E18, *n* = 8) to 203 ± 31 MΩ at P5--P7 (*n* = 5, *p* \< 0.05, Mann--Whitney test). In parallel, the percentage of mDA neurons displaying the hyperpolarization-activated cationic current Ih increased from 61% at E18 to 100% at P7. Amplitude of action potentials was measured from peak to after spike hyperpolarization (AHP) potential and their duration half-way between threshold and peak (half-width duration).

Amperometry
-----------

Coronal slices were placed in a chamber and perfused with O~2~ saturated ACSF at 32°C. We measured the evoked and not the spontaneous release of dopamine as performed in P9--14 primary cultures of mDA neurons (Kim et al., [@B21]) or 30--40 days organotypic slices of the striatum (Cragg et al., [@B6]) because the high perfusion rate of ACSF needed to keep slices healthy prevents such a measure. Stimulation was performed with a bipolar tungsten electrode with a tip separation of 100 μ m (World Precision Instruments TST33C05KT, stereo tungsten electrode, *in vitro* impedance of 1 MΩ) inserted into the striatum. We did not study DA overflow in response to median forebrain bundle (MFB) stimulation because medial sagittal slices containing the MFB cannot be reliably obtained at embryonic stages. To evoke a reproducible DA release, we used a train of four 100 Hz square pulses of 50 V amplitude and 100 μ s duration. To monitor the electrically evoked dopamine release, we used continuous amperometry with carbon fiber electrodes because it gives similar results as cyclic voltammetry in the striatum (Schmitz et al., [@B27]). The carbon fiber electrode (active surface 10 μ m in diameter and 500 μ m long; World Precision Instruments, CF10) was implanted into the striatum at an angle of 60° from vertical so that the entire length of the active surface was inside the slice at a depth of about 50 μ m from the surface. This was done in the ventrolateral and dorsomedial striatum where the evoked DA release was maximal and minimal respectively. The carbon fiber electrode was connected to a potentiostat (MicroC, World Precision instruments) to apply voltage and measure current. To measure DA release, the imposed voltage between the carbon fiber electrode and the Ag/AgCl pellet was 0.5 V. In response to the stimulus train, the current generated by oxidation of evoked dopamine released was recorded. To separate the evoked current from an artefact, the same stimulus protocol was done with 0V applied between the carbon electrode and the Ag/AgCl reference. At this voltage, no oxidation of DA should occur. Signals were digitized using a Digidata data acquisition system (Digidata 1440A) coupled to a PC running the clampex nine program responding to the Multiclamp700A amplifier. Results are presented as maximum response obtained per brain hemisphere. To measure DA release during the blockade of dopamine reuptake, we incubated the slices in nomifensine (10 μ M) for a minimum of 20 min. To test the calcium-dependence of dopamine release, we used a modified ACSF containing the following (in mM): 126 NaCl, 3.5 KCl, 1.2 NaH~2~PO~4~, 3.3 MgCl~2~, 25 NaHCO~3~, 11 glucose.

Immunocytochemistry
-------------------

To visualize the TH-positive fibers in the striatum we performed immunocytochemistry of TH in embryonic and early postnatal slices, and to identify the recorded cells we revealed the neurobiotin injected during whole-cell recordings in recorded slices, as previously described (Dehorter et al., [@B9]). Dendritic and axonal fields were reconstructed for morphological analysis using the Neurolucida system (MicroBrightField Inc., Colchester, VT).

Drugs
-----

Drugs were prepared as concentrated stock solutions and diluted in ACSF for bath application. Gabazine, *D*-amino pyruvate (D-APV), 6-cyano-7-nitroquinoxaline 2,3-dione (CNQX), Tetrodotoxin (TTX), Nifedipine, Thapsigargin and Nomifensine maleate were purchased from Sigma (St. Louis, MO, USA). ω--conotoxin GVIA was purchased from Alomone Labs (Jerusalem, Israel).

Statistical analysis
--------------------

Statistical results are given as means ± SEM. We performed statistical analysis using GraphPad Prism (GraphPad Software, Inc., La Jolla, CA): one-way ANOVA (Tukey\'s Test as *post hoc* test), Mann--Whitney test (non-parametric *t*-test), and paired *t*-tests as indicated in the results section. Differences were considered significant at *p* ≤ 0.05 (^\*\*\*^ for *p* ≤ 0.001, ^\*\*^ for *p* ≤ 0.01 and ^\*^ for *p* ≤ 0.05). We grouped the P5 and P7 sets of data since they did not present a statistical difference. In the box plots of Figures [1A](#F1){ref-type="fig"} and [5B](#F5){ref-type="fig"} the bottom and top of the boxes represent the 25^th^ and 75^th^, the band inside the box is the 50^th^ percentile (median) and the top and bottom vertical bars (whiskers) denote the maximum and minimum values.

![**Morphology of embryonic TH-positive midbrain neurons and distribution of TH-positive axons in the developing striatum. (A)** (Top) Reconstructed neurobiotin-filled, GFP-positive, mDA neurons at the indicated ages. Somas and dendrites are in black, axons in gray. (Bottom) Box plots of dendritic length (left) and number of dendritic ends (right) as a function of age. ^\*^Compared from E16 to E18 and from E18 to P0, Mann--Whitney test. **(B)** TH-positive axons (black staining) in the developing striatum (arrow) at the indicated ages.](fncel-06-00007-g0001){#F1}

Results {#s3}
=======

Embryonic mDA neurons project to the developing striatum
--------------------------------------------------------

Axons of E16 neurobiotin-filled mDA neurons project rostrally toward the striatum even when their somas do not have dendrites yet (Figure [1A](#F1){ref-type="fig"}). The dendritic length and number of dendritic ends of mDA neurons significantly increase from E16 (90 ± 31 μ m; 1.5 ± 0.4 ends; *n* = 13) to E18 (245 ± 66 μ m; 3.9 ± 0.6 ends; *n* = 7; *p* \< 0.05, Mann--Whitney test), and from E18 to P0 (1031 ± 287 μ m, 12 ± 3 ends; *n* = 6; *p* \< 0.05, Mann--Whitney test) (Figure [1A](#F1){ref-type="fig"}). Accordingly, a substantial diffuse innervation of the striatum by TH^+^ fibers is already present at E14--E16 in the ventro-lateral part of the striatum (Ohtani et al., [@B25]) (Figure [1B](#F1){ref-type="fig"}). Later at E18--P0, TH^+^ fibers invade the more dorsal regions of the striatum. Therefore, mDA neurons extend long axons that reach the striatum already at E16 before developing their dendritic tree.

Embryonic mDA neurons spontaneously generate intrinsically driven Ca^2+^ events
-------------------------------------------------------------------------------

From the 1052 fura-2-loaded/GFP-positive (mDA) imaged neurons recorded in a total of 45 movies, 412 spontaneously generated calcium events (Figures [2A,B](#F2){ref-type="fig"}). mDA neurons were already active at E16, the youngest age tested (Figures [2C,D](#F2){ref-type="fig"}). Embryonic (E16--E18) and early postnatal (P0--P7) mDA neurons generated two patterns of activity (Crepel et al., [@B8]): Ca^2+^ spikes that were sporadic brief Ca^2+^ events (1.41 ± 0.08 s duration, *n* = 264 neurons in 45 fields referred as 264/45) and long lasting Ca^2+^ plateaus (9 ± 0.3 s duration, 106/45; Figure [2C](#F2){ref-type="fig"}). These two patterns of activity significantly differed in duration (*p* \< 0.05, Mann--Whitney test). The percent of mDA neurons generating Ca^2+^ spikes was stable between E16 (28 ± 4% of fura-2 AM-loaded GFP neurons, 131/11), and P0 (32 ± 4%, 87/13), significantly decreased at P3 (11 ± 5%, 30/4, *p* \< 0.001, Mann--Whitney test, data not shown) and then remained stable until P7 (13 ± 3%, 11/12; Figure [2D](#F2){ref-type="fig"}). Ca^2+^ spikes had a low frequency at E16--E18 (0.05 ± 0.01 Hz, 166/16) that increased at P0 (0.09 ± 0.01 Hz) and P7 (0.16 ± 0.04 Hz, data not shown). The percent of mDA neurons generating Ca^2+^ plateaus was low at E16 (11 ± 3%, 37/11) and remained stable until P0 (10 ± 2%, 43/13) before decreasing at P7 (4 ± 2%, 5/12; Figure [2D](#F2){ref-type="fig"}). Ca^2+^ plateaus had a similar mean frequency (0.040 ± 0.004 Hz vs. 0.08 ± 0.04 Hz; *p* = 0.28 Mann--Whitney test) and a similar mean duration (8.9 ± 1.7 s vs. 8.6 ± 3.7 s; *p* = 0.67 Mann--Whitney test) at E16 and P7 (data not shown). Overall, the percent of spontaneously active mDA neurons generating at least one Ca^2+^ spike and/or one Ca^2+^ plateau did not change significantly between E16, E18, and P0 (39.5 ± 3.6%, 50.6 ± 10.5%, and 45 ± 4% of imaged mDA neurons, respectively, *p* = 0.4 between E16 and E18, and *p* = 0.7 between E18 and P0), and then significantly declined from P0 to P7 (17 ± 5% at P7; *p* \< 0.01, Mann--Whitney test). Ca^2+^ spikes and Ca^2+^ plateaus were poorly correlated between neurons (0.2% cell pairs significantly correlated, see materials and methods) at all ages tested.

![**Spontaneous Ca^2+^ activities of embryonic and early postnatal mDA neurons. (A)** Photomicrograph of the same fura 2-loaded sagittal slice from a P0 TH-GFP mouse excited with UV (left) or blue light (right) to show the slice loaded with the calcium dye fura 2-AM and the location of the GFP-positive structures, respectively. Recordings were performed in the midbrain, in the region of the substantia nigra (SN, white arrow). **(B)** Fluorescence images of the cells in the same fura 2-loaded (top left) and GFP-positive (top right) SN region. Manually detected contours of the cells from the corresponding fluorescence images (Middle). Superimposition of the two fields (Bottom, left). Open contours indicate fura 2-loaded cells and green-filled contours are fura 2-loaded/GFP-positive neurons. Rasterplot of the Ca^2+^ activity of the active fura 2-loaded/GFP-positive neurons from the field shown in **(B)** (Bottom, right). **(C)** Representative calcium fluorescence traces from GFP-positive neurons at the indicated ages showing spontaneously generated Ca^2+^ spikes (black) or Ca^2+^ plateaus (red). **(D)** Mean percentage (±SEM) of all active neurons (green), fura 2-loaded/GFP-positive midbrain neurons evoking at least one Ca^2+^ spike (black) or one Ca^2+^ plateau (red), as a function of age. ^\*^Compared to E16, E18, and P0, One-Way ANOVA.](fncel-06-00007-g0002){#F2}

Ca^2+^ spikes and Ca^2+^ plateaus were sensitive to blockers of Na^+^/Ca^2+^ voltage-gated channels since TTX (1 μ M) + nifedipin (10 μ M) dramatically decreased the percent of active mDA neurons from 30.2 ± 7.7% to 4.3 ± 1.3% at E16 (*p* \< 0.05, paired *t*-test, *n* = 4 slices), i.e., it decreased the activity of 94 ± 4% of the previously active E16 mDA cells (Figure [3A](#F3){ref-type="fig"}). Nifedipin alone at a concentration that specifically blocks L-type Ca^2+^ channels (3 μ M) decreased the calcium activity of 44 ± 14% of the previously active P1 mDA neurons (*n* = 8 slices, Figure [3B](#F3){ref-type="fig"}). Furthermore, ω-conotoxin GVIA (1 μ M), a specific blocker of N-type Ca^2+^ channels, decreased the calcium activity of 57 ± 7% of the previously active P1 mDA neurons (*n* = 4 slices, Figure [3C](#F3){ref-type="fig"}). In contrast, Ca^2+^ events recorded at P0 were totally insensitive to ionotropic GABA and glutamate receptor antagonists (44.9 ± 2.3% active vs. 37.2 ± 3.7% at P0, *p* = 0.7, paired *t*-test, i.e., 76.5 ± 6% of the previously active cells remained unaffected, Figure [3D](#F3){ref-type="fig"}). A few days later, at P3 the same synaptic blockers decreased the calcium activity of 69 ± 8% of the previously active mDA neurons (*n* = 4 slices, Figure [3E](#F3){ref-type="fig"}). In contrast, depletion of intracellular Ca^2+^ stores with thapsigargin (10 μ M) did not affect the number of cells generating Ca^2+^ spikes and Ca^2+^ plateaus, nor the frequency of these events (24.5 ± 4.1% control active vs. 24.6 ± 4.3% at P1, *p* = 0.9, paired *t*-test, i.e., 76 ± 10% of the active GFP-positive cells identified before thapsigargin treatment had their activity unaffected by the treatment, data not shown). These results showed that E16-P1 mDA neurons spontaneously generate intrinsically driven, L- and N-type mediated Ca^2+^ events. Only starting from P3, are these Ca^2+^ events sensitive to synaptic blockers suggesting that synapse-driven inputs to mDA neurons operate during the first postnatal week but not before.

![**Pharmacology of the spontaneous Ca^2+^ activities of embryonic and early postnatal mDA neurons.** Representative calcium fluorescence traces from mDA neurons and corresponding quantitative data at the indicated ages showing the effect of TTX (1 μ M)---nifedipin (10 μ M) **(A)** nifedipin (3 μ M) **(B)** ω-conotoxin GVIA (1 μ M) **(C)** and blockers of ionotropic glutamate and GABA receptors \[APV (40 μ M)---CNQX (10 μ M)---Gabazine (5 μ M), **D** and **E**\].](fncel-06-00007-g0003){#F3}

At birth, half the mDA neurons spontaneously generate intrinsically driven Na^+^ action potentials
--------------------------------------------------------------------------------------------------

In contrast to their capacity to generate Ca^2+^ events (Figures [2B](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}), E16 embryonic mDA neurons (*n* = 16) did not generate spontaneous (Figure [4A](#F4){ref-type="fig"}) or evoked (Figure [4B](#F4){ref-type="fig"}) Na^+^ spikes. They started to generate spontaneous Na^+^ spikes around birth since 28% and 50% of the recorded mDA neurons at E18 and P0, respectively, (*n* = 18; *n* = 12), spontaneously fired action potentials with a mean amplitude of 44.8 ± 5.4 mV and 52.6 ± 3.3 mV (Figures [4A--C](#F4){ref-type="fig"}). At P7, 100% of the recorded mDA neurons were spontaneously active (amplitude: 73.6 ± 4.5 mV; *n* = 10). Spike half-width duration significantly decreased from E18--P0 (3.8 ± 0.6 ms, *n* = 5; 4.2 ± 0.6, *n* = 6) to P7 (2.2 ± 0.2 ms, *n* = 10; *p* \< 0.05, Mann--Whitney test; Figure [4D](#F4){ref-type="fig"}) but mean spontaneous firing frequency did not significantly increase from E18--P0 to P7 (0.2 ± 0.1 Hz at E18; 0.4 ± 0.2 Hz at P0; 0.6 ± 0.2 Hz at P7; Figure [4E](#F4){ref-type="fig"}). Therefore, half of the mDA neurons are already capable of generating spikes at birth (see Figure [2](#F2){ref-type="fig"}).

![**Firing patterns of embryonic and early postnatal mDA neurons.** Spontaneous **(A)** and evoked **(B)** membrane potential changes recorded in whole-cell configuration, current clamp mode from midbrain GFP-positive neurons at the indicated ages. Distribution of the amplitude **(C)** half-width duration **(D)** and frequency **(E)** of spontaneous Na^+^ action potentials as a function of age. ^\*^Compared to E18 and P0.](fncel-06-00007-g0004){#F4}

When stimulated, tyrosine-hydroxylase positive fibers release dopamine in the striatum at birth
-----------------------------------------------------------------------------------------------

In agreement with the presence of TH^+^ fibers in the embryonic striatum, we detected from E18 DA release in the striatum in response to local stimulation (19.7 ± 1.5 pA, *n* = 13; Figures [5A,B](#F5){ref-type="fig"}). This evoked DA release significantly increased at birth (P0) to 43.1 ± 4.3 pA (*p* \< 0.001, One-way ANOVA; *n* = 25) and stayed stable during the first postnatal week. The evoked DA release observed at E18 and P0 was entirely dependent on external Ca^2+^ ions, since the response disappeared in the absence of Ca^2+^ ions, and was rescued in the presence of Ca^2+^ ions (Figures [5A,B](#F5){ref-type="fig"}) To further support the view that the changes in oxidation current evoked by striatal stimulation actually correspond to an evoked dopamine overflow (Benoit-Marand et al., [@B2]), nomifensine (10 μ M) was added to the perfusion medium to inhibit dopamine reuptake. This did not alter the rising phase of dopamine overflow which corresponds to dopamine release, but slowed the kinetics of the decreasing phase which depends on dopamine reuptake (Figure [5A](#F5){ref-type="fig"}). Dopamine half-decay was significantly increased by nomifensine treatment (20 min) at P7 (0.4 ± 0.1 to 3.7 ± 0.3 s, *p* \< 0.001 paired *t*-test, *n* = 5), and P25--40 (0.5 ± 0.2 to 3.7 ± 1 s, *p* \< 0.05 paired *t*-test, *n* = 5; Figure [5B](#F5){ref-type="fig"}). These results confirmed the perinatal expression of the dopamine transporter in rodents (Galineau et al., [@B13]). At E18 and P0, the decay phase in the presence of nomifensine was too long and precluded its measure. This could be due to the fact that at these young ages the competitive inhibitor nomifensine, at the dose used, could not be rapidly displaced from its binding sites on the dopamine transporter (Tuomisto, [@B34]; Jones et al., [@B18]; Katz et al., [@B19]) by the small amount of evoked dopamine overflow.

![**Evoked dopamine release in the developing striatum as a function of age. (A)** Example traces of dopamine overflow (in pA) evoked by a train of four pulses in control ACSF (control, black), in the absence of external Ca^2+^ ions (0 mM Ca^2+^, blue) or in the presence of nomifensine (10 μ M, green) in the bath, at the indicated ages. **(B)** Box plots of the peak amplitude of evoked dopamine (DA) release in the striatum as a function of age (left), its relative decrease in the absence of external Ca^2+^ ions at E18 and P0 with recovery after returning to control ACSF (middle), and its half-decay in the presence of nomifensine as a function of age (right). DA release: ° *p* \< 0.05 compared to E18; \#\#\#*p*\< 0.001 compared to P0, P7, P26--40; ^\*\*\*^*p* \< 0.001 compared to P26--40; one-way ANOVA. Calcium-dependence: ^\*^*p* \< 0.05, ^\*\*\*^*p* \< 0.001 compared to 2 mM Ca^2+^, paired *t*-test. Nomifensine: ^\*^*p* \< 0.05, ^\*\*\*^*p* \< 0.001 compared to control, paired *t*-test.](fncel-06-00007-g0005){#F5}

Discussion {#s4}
==========

Here we show that mouse mDA neurons project to the striatum and spontaneously generate intrinsically driven Ca^2+^ events mediated by N- and L-type Ca^2+^ channels during embryonic life. At birth, they generate Na^+^ spikes and release dopamine in the developing striatum in a Ca^2+^-dependent manner.

The dynamic two-photon calcium imaging technique enabled us to record the activity of large neuronal populations when compared to patch-clamp recordings of single neurons. Around 50% of mDA neurons generated spontaneous voltage-gated Ca^2+^ spikes and/or Ca^2+^ plateaus already at E16. Both types of activity previously described in the developing cortex, hippocampus and striatum, correspond to single action potentials and bursts of spikes, respectively, (Crepel et al., [@B8]; Allene et al., [@B1]; Dehorter et al., [@B10]). The general sequence of patterns generated by mDA neurons is not without similarities with that reported in cortical and basal ganglia structures in these earlier studies. Clearly, non-synapse-driven, voltage-gated currents precede the operation of synapse-driven events. However, in contrast to cortical and striatal networks, Ca^2+^ plateaus were not correlated between mDA neurons. Since correlated calcium plateaus in small cell assemblies depend on gap junctions required for the formation of synaptically connected networks (Todd et al., [@B32]), their absence might be accounted for by the absence of connections (recurrent collaterals) between adult A9 mDA neurons (Chen et al., [@B5]). This can also be due to the small number of mDA neurons generating Ca^2+^ plateaus in each imaged field, thus reducing the probability of correlation. Also, whether the synapse-driven patterns recorded from mDA neurons are similar to the giant depolarizing potentials (GDPs) described in cortical and more recently in striatal structures (Dehorter et al., [@B10]) remains to be clarified. The difficulty of finding mDA neurons generating synchronized synapse-driven events most likely reflects the maturation of incoming fibers to the structure investigated. In contrast to the hippocampus and neocortex, but similarly as the striatum, there are no intrinsic glutamatergic neurons in the SN, thereby conditioning the generation of synchronized patterns by the arrival of external inputs: here the pedunculopontine and subthalamic nuclei that may have a delayed maturation. The other source of glutamate could arise from the recurrent collaterals of the midbrain dopaminergic neurons that co-release glutamate in the adult striatum (Tecuapetla et al., [@B30]). At any rate, the development of an *in vitro* embryonic slice with enough intact inputs from these structures is needed to solve this issue.

Although we cannot completely exclude the possibility that a subthreshold calcium-dependent dopamine release is present before E18--P0 this would be without functional consequence since Na^+^ spikes required to that effect are not generated by most mDA neurons before E18. Interestingly, around birth, mDA neurons generate Ca^2+^ events partly mediated by N-type Ca^2+^ channels, the same channels involved in synaptic DA release in the adult rodent striatum *in vivo* and *in vitro* (Herdon and Nahorski, [@B17]; Bergquist et al., [@B3]).

What could be the functional role of dopamine signals in the developing striatum? Dopamine has been suggested to modulate multiplication, migration, and wiring of target neurons. The activation of dopamine receptors by exogenous dopamine or dopamine agonists regulates the cell cycle of striatal progenitors in the lateral ganglionic eminence in explant cultures or in mice *in vivo* from E13 (Ohtani et al., [@B25]). From E15, dopaminergic agonists, or the invalidation of D1 or D2 receptors, differentially modulate the migration of GABAergic interneurons to the cerebral wall in embryonic mouse forebrain organotypic slices (Crandall et al., [@B7]). In addition, the activation of dopamine receptors in primary striatal neuronal cultures (7--14 days cultures obtained from E16--17 striata) limits the extent of collateral GABAergic synaptogenesis between developing medium spiny neurons (Goffin et al., [@B15]). Early effects of dopamine before E18 could result from activity-independent release of dopamine in the ganglionic eminences as described for glutamate and GABA in the developing hippocampus and shown to be quite efficient in modulating migration (Demarque et al., [@B11]; Manent and Represa, [@B22]). The possible implications of activity-dependent release of DA on striatal maturation remain to be investigated. But, interestingly, the fraction of medium spiny neurons generating glutamate and GABA spontaneous synaptic activity in the developing striatum also considerably develops during the first postnatal week in mice (Dehorter et al., [@B10]), suggesting an important stimulation of the developmental process after birth.

To conclude, the present work suggests a developmental sequence of mDA neurons with features that are common and specific to these neurons. In a previous study, we showed that striatal neurons follow an abrupt alteration of their properties in time to start controlling motricity in pups (Dehorter et al., [@B10]). Future studies will have to interconnect these events and determine the impact of dopaminergic synapses on the operation of early striatal neurons.
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